Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance

被引:46
作者
Gyurkovska, Valeriya [1 ]
Ivanovska, Nina [1 ]
机构
[1] Inst Microbiol, Dept Immunol, 26 G Bonchev Str, Sofia 1113, Bulgaria
关键词
TRAIL; TRAIL-deficient mice; Viral infections; Bacterial infections; GASTRIC EPITHELIAL-CELLS; T-CELLS; IFN-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; VIRUS-INFECTION; GENE-EXPRESSION; DENDRITIC CELLS; NK CELLS; KAPPA-B; PHASE-I;
D O I
10.1007/s00011-016-0934-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Apoptotic death of different cells observed during infection is thought to limit overwhelming inflammation in response to microbial challenge. However, the underlying apoptotic death mechanisms have not been well defined. Tumor necrosis factor (TNF) related apoptosis-inducing ligand (TRAIL) is a type II transmembrane protein belonging to the TNF superfamily, which is involved not only in tumor growth suppression but in infection control and also in the regulation of both innate and adaptive immune responses. In this review, we have summarized data of recent studies on the influence of the TRAIL/TRAIL receptor (TRAIL-R) system on the development of viral and bacterial infections. TRAIL may have a dual function in the immune system being able to kill infected cells and also to participate in the pathogenesis of multiple infections. Moreover, many pathogens have evolved mechanisms to manipulate TRAIL signaling thus increasing pathogen replication. Present data highlight an essential role for the TRAIL/TRAIL-R system in the regulation and modulation of apoptosis and show that TRAIL has distinct roles in pathogenesis and pathogen elimination. Knowledge of the factors that determine whether TRAIL is helpful or harmful supposes its potential therapeutic implications that are only beginning to be explored.
引用
收藏
页码:427 / 437
页数:11
相关论文
共 110 条
[11]   The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium avium [J].
Borges, M. ;
Rosa, G. T. ;
Appelberg, R. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 (03) :407-416
[12]   TRAIL Modulates the Immune System and Protects against the Development of Diabetes [J].
Bossi, Fleur ;
Bernardi, Stella ;
Zauli, Giorgio ;
Secchiero, Paola ;
Fabris, Bruno .
JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
[13]   CD8 T cells utilize TRAIL to control influenza virus infection [J].
Brincks, Erik L. ;
Katewa, Arna ;
Kucaba, Tamara A. ;
Griffith, Thomas S. ;
Legge, Kevin L. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (07) :4918-4925
[14]   A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies [J].
Camidge, D. Ross ;
Herbst, Roy S. ;
Gordon, Michael S. ;
Eckhardt, S. Gail ;
Kurzrock, Razelle ;
Durbin, Blythe ;
Ing, Josephine ;
Tohnya, Tanyifor M. ;
Sager, Jason ;
Ashkenazi, Avi ;
Bray, Gordon ;
Mendelson, David .
CLINICAL CANCER RESEARCH, 2010, 16 (04) :1256-1263
[15]  
CAMPBELL LA, 1993, FERTIL STERIL, V59, P45
[16]   Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection [J].
Ciesek, S. ;
Liermann, H. ;
Hadern, J. ;
Greten, T. ;
Tillmann, H. L. ;
Cornberg, M. ;
Aslan, N. ;
Manns, M. P. ;
Wederneyer, H. .
JOURNAL OF VIRAL HEPATITIS, 2008, 15 (03) :200-211
[17]   Reovirus-induced apoptosis is mediated by TRAIL [J].
Clarke, P ;
Meintzer, SM ;
Gibson, S ;
Widmann, C ;
Garrington, TP ;
Johnson, GL ;
Tyler, KL .
JOURNAL OF VIROLOGY, 2000, 74 (17) :8135-8139
[18]   Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer [J].
Dalby, Kevin N. ;
Tekedereli, Ibrahim ;
Lopez-Berestein, Gabriel ;
Ozpolat, Bulent .
AUTOPHAGY, 2010, 6 (03) :322-329
[19]   Pathogenic potential of interferon αβ in acute influenza infection [J].
Davidson, Sophia ;
Crotta, Stefania ;
McCabe, Teresa M. ;
Wack, Andreas .
NATURE COMMUNICATIONS, 2014, 5
[20]   TRAIL-R as a negative regulator of innate immune cell responses [J].
Diehl, GE ;
Yue, HH ;
Hsieh, K ;
Kuang, AA ;
Ho, M ;
Morici, LA ;
Lenz, LL ;
Cado, D ;
Riley, LW ;
Winoto, A .
IMMUNITY, 2004, 21 (06) :877-889